PL82159B2 - - Google Patents

Download PDF

Info

Publication number
PL82159B2
PL82159B2 PL15560072A PL15560072A PL82159B2 PL 82159 B2 PL82159 B2 PL 82159B2 PL 15560072 A PL15560072 A PL 15560072A PL 15560072 A PL15560072 A PL 15560072A PL 82159 B2 PL82159 B2 PL 82159B2
Authority
PL
Poland
Prior art keywords
toxic
kaolin
stearin
talc
crystal violet
Prior art date
Application number
PL15560072A
Other languages
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to PL15560072A priority Critical patent/PL82159B2/pl
Publication of PL82159B2 publication Critical patent/PL82159B2/pl

Links

Landscapes

  • Dental Preparations (AREA)

Description

Pierwszenstwo: Zgloszenie ogloszono: 30.05.1973 Opis patentowy opublikowano: 25.11.1975 82159 KI. 22g,13/00 MKP' C09d 13/00 Twórcywynalazku: Maria Kleinrok, Ewa Drewnowska Uprawniony z patentu tymczasowego: Akademia Medyczna, Lublin (Polska) Nietoksyczny precik kreslarski do zaznaczania obrysów na blonie sluzowej jamy ustnej Przedmiotem wynalazku jest nietoksyczny precik kreslarski do zaznaczania obrysów na blonie sluzowej jamy ustnej stosowany w protetyce stomatologicznej.Do obrysowywania zasiegu protezy na blonie sluzowej w jamie ustnej badz zaznaczania miejsc korekty protez, stosuje sie powszechnie preciki olówka kopiowego bez wzgledu na stopien ich toksycznosci i twardosci.Preciki sa wykonywane z mieszaniny grafitu, tragantu, talku, stearyny, kaolinu, weglanu, rn^nezu oraz skladników barwiacych - fioletu metylowego i fioletu krystalicznego. Do najmniej toksyczn\ a< ra preciki wykonane z nastepujacej mieszaniny substancji chemicznych: fiolet krystaliczny 15,5%, tali cchniczny 50%, stearyna 10%, kaolin 15,5%, i tragant 9,5%. Przeprowadzone badania na królikach wykazaly, ze w precikach tych stosunkowo wysoka zawartosc fioletu krystalicznego zasadowego wywoluje martwice i stany zapalne w przypadku zabarwienia miejsca zranionego.Celem wynalazku jest takie dobranie skladników substancji chemicznych które by nie posiadaly wlasciwosci toksycznych z równoczesnym zachowaniem wymaganych wlasciwosci barwiacych, wytrzymaloscio¬ wych i twardosci precików. Cel ten osiagnieto przez wprowadzenie do mieszaniny nastepujacych przykladowych znanych skladników: stearyny 16%, talku 52%, kaolinu 19% i tragantu 10% oraz czynnika barwiacego korzystnie fioletu krystalicznego od 2 do 4% wagowych. PL PLPriority: Application announced: May 30, 1973 Patent description was published: November 25, 1975 82159 KI. 22g, 13/00 MKP 'C09d 13/00 Inventors: Maria Kleinrok, Ewa Drewnowska Authorized by the provisional patent: Medical Academy, Lublin (Poland) Non-toxic drafting stamen for marking outlines on the mucous membrane of the oral cavity The subject of the invention is a non-toxic drescent stalk for marking outlines on the oral mucosa, used in dental prosthetics. To outline the range of the prosthesis on the mucosa in the mouth or to mark the places of denture correction, stamens of the copy pencil are commonly used, regardless of their degree of toxicity and hardness. The dies are made of a mixture of graphite, tragant, talc, stearin, kaolin, carbonate, other nez, and the coloring components - methyl violet and crystal violet. The least toxic sticks are made of the following mixture of chemicals: crystal violet 15.5%, technical waist 50%, stearin 10%, kaolin 15.5%, and traganthus 9.5%. The tests carried out on rabbits have shown that the relatively high content of basic crystal violet in these precursors causes necrosis and inflammation in the case of staining of the wounded area. The aim of the invention is to select the components of chemical substances that would not have toxic properties while maintaining the required coloring properties, strength and durability. and the hardness of the stamens. This object was achieved by incorporating into the mixture the following exemplary known ingredients: stearin 16%, talc 52%, kaolin 19% and tragantite 10% and a coloring agent preferably crystal violet from 2 to 4% by weight. PL PL

Claims (2)

1. Zastrzezenie patentowe 1. Nietoksyczny precik kreslarski do zaznaczania obrysów na blonie sluzowej w jamie ustnej zawierajacy stearyne, talk, kaolin i tragant, znamienny tym, ze posiada czynnik barwiacy korzystnie fiolet krystalicz¬ ny w ilosci1. Claim 1. A non-toxic stearm for marking contours on the oral mucosa containing stearin, talc, kaolin and tragant, characterized in that it has a coloring agent preferably crystalline violet in an amount 2. -4% wagowych. PL PL2. -4% by weight. PL PL
PL15560072A 1972-05-26 1972-05-26 PL82159B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL15560072A PL82159B2 (en) 1972-05-26 1972-05-26

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL15560072A PL82159B2 (en) 1972-05-26 1972-05-26

Publications (1)

Publication Number Publication Date
PL82159B2 true PL82159B2 (en) 1975-10-31

Family

ID=19958705

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15560072A PL82159B2 (en) 1972-05-26 1972-05-26

Country Status (1)

Country Link
PL (1) PL82159B2 (en)

Similar Documents

Publication Publication Date Title
Holt et al. The anti-microbial effect against enterococcus faecalis and the compressive strength of two types of mineral trioxide aggregate mixed with sterile water or 2% chlorhexidine liquid
HUT57008A (en) Herbicidal compositions comprising 3-aryluracyl derivative as active ingredient and process for producing for producing the active ingredient
ES8202541A1 (en) Sulfonyl ureas, processes for their preparation and pharmaceutical compositions containing these compounds.
CA1302659C (en) Dental impression material
CO5271691A1 (en) NEW COMPOUNDS
PT1292594E (en) QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMORS
FI913478A0 (en) DIAZINDERIVAT.
FI830360L (en) TOPISKA PHARMACEUTICAL COMPOSITION
FI20001696A7 (en) Biologically active material
HUT52040A (en) Process for producing diaryl-derivatives and pharmaceutical compositions containing them
Selden Bone wax as an effective hemostat in periapical surgery
Garcia et al. Staining susceptibility of new calcium aluminate cement (E ndo B inder) in teeth: a 1‐year in vitro study
MX3783E (en) PROCEDURE FOR THE PREPARATION OF COMPOSITIONS FOR THE TREATMENT OF MOUTH AND DENTAL DISEASES
PL82159B2 (en)
ES2269913T3 (en) DUST MIXTURE FOR BIOLOGICAL CEMENTS OF REASORBIBLE CALCIUM PHOSPHATE.
Wennberg et al. Cytotoxicity evaluation of temporary filling materials.
Ji et al. Effects of a novel hydration accelerant on the biological and mechanical properties of white mineral trioxide aggregate
JPS56115793A (en) Phosphonohydroxyacetic acid* its salt* their manufacture and drug thereof as active component
TR200103144T2 (en) New compounds
ES2145740T3 (en) GROWTH, PREPARATION AND USE FACTOR COMPOSITIONS.
IL60863A (en) 5-(chlorophenyl)-6h-1,3,4-thiadiazine-2-amine derivatives,their preparation and pharmaceutical compositions containing them
IT8024152A0 (en) DERIVATIVES OF 1,1,2-TRIFENYLPROPANE AND 1,1,2-TRIFENYLPROPENE, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS
H. Alfahdawi et al. Evaluate (0.2% CHX) disinfection solution effects Incorporation on the setting time, setting expansion and compressive strength of Dental Stone
Mohammad et al. Effects of different disinfectant additives on compressive strength of dental stone
ES472528A1 (en) Derivatives of benzenesulfonamide, method for their preparation and pharmaceutical compositions containing them.